Management Team

Keith Rubin, M.D.
Founder and Chief Executive Officer
Ken Solovay
Chief Operating Officer
Stephanie Noviello, M.D., M.P.H.
Chief Medical Officer

Luis Rios-Nogales, M.D., Ph.D., M.B.A.
Executive VP and Chief Development Officer
André Morais Campos
Vice President of Global Clinical Operations
Stanley Kim, Ph.D., Esq.
Senior Vice President, Intellectual Property and Contracts
Marcel Thalen, Ph.D.
Executive Director, Drug Product Development

Peter Goldstein
Executive Director, Vaccine Platform Development
Theressa Creighton
Senior Clinical Project Manager
Steve Glazer, M.D.
Director, New Research Programs
Walter Greenblatt
Corporate Development

Jim Ramadei
Matthew Bross
Administrative Manager

Copyright 2013-2022 ILiAD Biotechnologies
Financial Conflict of Interest (FCOI) Policy